NX-3911

N/A

Report date: 2025/06/12 11:47:03
NME

Base Information

Drug NameNX-3911
Drug Alias NameNX-3911
ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)
Mechanisms of ActionSignal transducer and activator of transcription 6 degraders
TargetsSignal transducer and activator of transcription 6
Therapy Area/IndicationsInflammationDermatitis, AtopicAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNurix Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesSanofiNurix Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsInflammationDermatitis, AtopicAsthma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A